Literature DB >> 23032361

African-American men with low-grade prostate cancer have higher tumor burdens: results from the Duke Prostate Center.

M Tsivian1, L L Bañez, C J Keto, M R Abern, P Qi, L Gerber, J W Moul, T J Polascik.   

Abstract

BACKGROUND: To investigate racial differences in tumor burden (cancer volume, cancer percentage and cancer to PSA ratios) in a large cohort of men undergoing radical prostatectomy (RP).
METHODS: Demographic, clinical and pathological data of patients undergoing RP between 1993-2010 were reviewed and compared between African-American (AA) and non African-American (nAA) men. Further assessments of pathological tumor burden (estimated tumor volume, percent of cancer involvement, and estimated tumor volume/PSA ratios) were performed across Gleason score categories.
RESULTS: Of 4157 patients in the analysis, 604 (14.5%) were AA. Overall, AA patients were younger, had higher Gleason scores, PSA levels and incidence of palpable disease (all P < 0.001). Despite comparable prostate weights (39.4 vs. 39.6 g), AA men had higher percent cancer involvement and estimated tumor volume (all P < 0.001) but similar estimated tumor volume/PSA ratios ( P> 0.05). When stratified by Gleason scores, prostate weights were comparable; however, estimated tumor volume, percent cancer involvement and estimated tumor volume/PSA ratios were higher in AA men with low grade (≤ 6) prostate cancer (PCa), similar in intermediate grade (7-8) and lower in high grade (9-10) PCa compared to nAA men.
CONCLUSIONS: In this large series, AA patients had higher disease burden (estimated tumor volume, percent cancer involvement, estimated tumor volume/PSA ratios) compared to nAA but this association was especially pronounced in low grade (Gleason ≤ 6) cancers. These data depict a complex picture of relations between race and tumor burden across the spectrum of PCa aggressiveness. Further investigation is warranted to understand the mechanisms of racial disparities in PCa.

Entities:  

Mesh:

Year:  2012        PMID: 23032361     DOI: 10.1038/pcan.2012.39

Source DB:  PubMed          Journal:  Prostate Cancer Prostatic Dis        ISSN: 1365-7852            Impact factor:   5.554


  9 in total

1.  Pathological and Biochemical Outcomes among African-American and Caucasian Men with Low Risk Prostate Cancer in the SEARCH Database: Implications for Active Surveillance Candidacy.

Authors:  Michael S Leapman; Stephen J Freedland; William J Aronson; Christopher J Kane; Martha K Terris; Kelly Walker; Christopher L Amling; Peter R Carroll; Matthew R Cooperberg
Journal:  J Urol       Date:  2016-06-25       Impact factor: 7.450

Review 2.  Prostate cancer in men of African origin.

Authors:  Kathleen F McGinley; Kae Jack Tay; Judd W Moul
Journal:  Nat Rev Urol       Date:  2015-12-31       Impact factor: 14.432

3.  Engaging African American Men as Citizen Scientists to Validate a Prostate Cancer Biomarker: Work-in-Progress.

Authors:  Karriem S Watson; Vida Henderson; Marcus Murray; Adam B Murphy; Josef Ben Levi; Tiffany McDowell; Alfreda Holloway-Beth; Pooja Gogana; Michael A Dixon; LeAndre Moore; Ivanhoe Hall; Alexander Kimbrough; Yamilé Molina; Robert A Winn
Journal:  Prog Community Health Partnersh       Date:  2019

4.  The association between race and prostate cancer risk on initial biopsy in an equal access, multiethnic cohort.

Authors:  Alexis R Gaines; Elizabeth L Turner; Patricia G Moorman; Stephen J Freedland; Christopher J Keto; Megan E McPhail; Delores J Grant; Adriana C Vidal; Cathrine Hoyo
Journal:  Cancer Causes Control       Date:  2014-05-31       Impact factor: 2.506

5.  Does larger tumor volume explain the higher prostate specific antigen levels in black men with prostate cancer--Results from the SEARCH database.

Authors:  Zachary Klaassen; Lauren Howard; Martha K Terris; William J Aronson; Matthew R Cooperberg; Christopher L Amling; Christopher J Kane; Stephen J Freedland
Journal:  Cancer Epidemiol       Date:  2015-10-06       Impact factor: 2.984

Review 6.  Progression on active surveillance for prostate cancer in Black men: a systematic review and meta-analysis.

Authors:  Hari T Vigneswaran; Luke Mittelstaedt; Alessio Crippa; Martin Eklund; Adriana Vidal; Stephen J Freedland; Michael R Abern
Journal:  Prostate Cancer Prostatic Dis       Date:  2021-07-08       Impact factor: 5.554

7.  Proteomic Upregulation of Fatty Acid Synthase and Fatty Acid Binding Protein 5 and Identification of Cancer- and Race-Specific Pathway Associations in Human Prostate Cancer Tissues.

Authors:  Jennifer S Myers; Ariana K von Lersner; Qing-Xiang Amy Sang
Journal:  J Cancer       Date:  2016-07-05       Impact factor: 4.207

8.  Proteomic characterization of paired non-malignant and malignant African-American prostate epithelial cell lines distinguishes them by structural proteins.

Authors:  Jennifer S Myers; Karin A Vallega; Jason White; Kaixian Yu; Clayton C Yates; Qing-Xiang Amy Sang
Journal:  BMC Cancer       Date:  2017-07-11       Impact factor: 4.638

9.  Identification and Characterization of Key Differentially Expressed Genes Associated With Metronomic Dosing of Topotecan in Human Prostate Cancer.

Authors:  Taraswi Mitra Ghosh; Jason White; Joshua Davis; Suman Mazumder; Teeratas Kansom; Elena Skarupa; Grafton S Barnett; Gary A Piazza; R Curtis Bird; Amit K Mitra; Clayton Yates; Brian S Cummings; Robert D Arnold
Journal:  Front Pharmacol       Date:  2021-12-06       Impact factor: 5.810

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.